Journal of Applied Physiology, Vol 80, Issue 1 203-207, Copyright © 1996 by American Physiological Society

ARTICLES

Blocked ETA receptors prevent ischemia and reperfusion injury in rat lungs

P. L. Khimenko, T. M. Moore and A. E. Taylor
Department of Physiology, College of Medicine, University of South Alabama, Mobile 36688, USA.

The effects of endothelin (ET)-A (ETA)- and ETB-receptor agonist and antagonists were studied in isolated buffer-perfused rat lungs subjected to 45 min of ischemia followed by 105 min of reperfusion (I/R). For the I/R group after 30 and 90 min of reperfusion, the Kfc had increased three- and fivefold above control values, respectively (P < 0.01), and the number of circulating neutrophils in the perfusate decreased by 65 +/- 7.65%. Both an ETA-receptor antagonist (BQ-610) and an ETAB-receptor antagonist (PD-156707-0015) given before the ischemic period protected the lung endothelial barrier from injury associated with I/R. Also, these compounds attenuated the I/R-induced neutrophil accumulation in the lung (31.94 +/- 4.16 and 34.38 +/- 1.05%, respectively; P < 0.01 compared with I/R). Neither an ETB-receptor agonist (IRL-1620) nor an ETB-receptor antagonist (IRL-1038) affected the I/R-induced endothelial injury. In addition, they did not alter the number of circulating polymorphonuclear cells during I/R. ET-1 administration alone caused a dose-dependent increase in pulmonary arterial pressure, but no measurable increase in microvascular permeability occurred. We conclude that ET-1 is involved in I/R-induced lung endothelial injury and speculate that it acts in concert with some other coactivator(s), most likely platelet-activating factor, through ETA receptors. This mechanism requires polymorphonuclear leukocyte activation with subsequent release of oxygen radicals and/or expression of adhesive molecules on the neutrophil surface.

This article has been cited by other articles:

				G. Matute-Bello, C. W. Frevert, and T. R. Martin Animal models of acute lung injury Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L379 - L399. [Abstract] [Full Text] [PDF]

				E. M. Whitman, S. Pisarcik, T. Luke, M. Fallon, J. Wang, J. T. Sylvester, G. L. Semenza, and L. A. Shimoda Endothelin-1 mediates hypoxia-induced inhibition of voltage-gated K+ channel expression in pulmonary arterial myocytes Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L309 - L318. [Abstract] [Full Text] [PDF]

				H. SHENNIB, A. G. L. LEE, J. Q. KUANG, M. YANAGISAWA, E. H. OHLSTEIN, and A. GIAID Efficacy of Administering an Endothelin-receptor Antagonist (SB209670) in Ameliorating Ischemia-Reperfusion Injury in Lung Allografts Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1975 - 1981. [Abstract] [Full Text] [PDF]

				J. R. Michael, B. A. Markewitz, and D. E. Kohan Oxidant stress regulates basal endothelin-1 production by cultured rat pulmonary endothelial cells Am J Physiol Lung Cell Mol Physiol, October 1, 1997; 273(4): L768 - L774. [Abstract] [Full Text] [PDF]